← Leaderboards
Susanna Nila Basappa
Mayo Clinic Rochester
$236,956
Attributed
$236,956
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $51.8K · FY2019–23$100K$75K$50K$25K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$236,956 · 1
By mechanism
F30$236,956 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Deborah Rhodes$1,619,926
- Zhenkun Lou$18,569,951
- Liewei Wang$11,536,599
- Carrie B Hruska$2,000,334
- Mostafa Fatemi$15,327,150
Others in their field
Other Emerging Leaders on “Advisory Committees”
- Claudia Valmonte · The Emmes Company, Llc$37,865,589
- James Lu · Helix$12,461,593
- Hemali Phatnani · New York University School Of Medicine$12,067,974
- Patrick A Flume · Medical University Of South Carolina$11,656,627
- Sonia Savelli · University Of Washington$11,147,222
- Rajni Samavedam · Booz Allen Hamilton$9,935,296
Research focus
Advisory CommitteesBiopsyBreastBreast Cancer DetectionBreast Cancer DiagnosisBreast Cancer Risk FactorBreast Cancer SurvivalBreast DensityBreast ExamBreast ImagingBreast Magnetic Resonance ImagingCancer DetectionCancer TypeCareerCaringCessation Of LifeCharacteristicsClinicCohortConsentConsumptionCostCountyData Set
Grant awards (5)
Cancer stage and diagnostic triggers as mortality surrogate to validate supplemental breast imaging use in women with dense breasts$33,632
F30 · FY2023 · CA · contact PI
Cancer stage and diagnostic triggers as mortality surrogate to validate supplemental breast imaging use in women with dense breasts$51,752
F30 · FY2022 · CA · contact PI
Cancer stage and diagnostic triggers as mortality surrogate to validate supplemental breast imaging use in women with dense breasts$51,036
F30 · FY2021 · CA · contact PI
Cancer stage and diagnostic triggers as mortality surrogate to validate supplemental breast imaging use in women with dense breasts$50,520
F30 · FY2020 · CA · contact PI
Cancer stage and diagnostic triggers as mortality surrogate to validate supplemental breast imaging use in women with dense breasts$50,016
F30 · FY2019 · CA · contact PI